α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation
α-Synuclein aggregation is a hallmark of Parkinson's disease and related synucleinopathies. Extracellular α-synuclein fibrils enter naive cells via endocytosis, followed by transit into the cytoplasm to seed endogenous α-synuclein aggregation. Intracellular aggregates sequester numerous proteins, including subunits of the endosomal sorting complexes required for transport (ESCRT)-III system for endolysosome membrane repair, but the toxic effects of these events remain poorly understood. Using cellular models and in vitro reconstitution, we found that α-synuclein fibrils interact with a conserved α-helix in ESCRT-III proteins. This interaction sequesters ESCRT-III subunits and triggers their proteasomal destruction in a process of "collateral degradation." These twin mechanisms deplete the available ESCRT-III pool, initiating a toxic feedback loop. The ensuing loss of ESCRT function compromises endolysosome membranes, thereby facilitating escape of aggregate seeds into the cytoplasm, facilitating a "second wave" of templated aggregation and ESCRT-III sequestration. We suggest that collateral degradation and the triggering of self-perpetuating systems are general mechanisms of sequestration-induced proteotoxicity.
Authors
- Jiuchun Zhang
- Cole S. Sitron (ORCID: https://orcid.org/0000-0001-6584-5926)
- Ana Galesic (ORCID: https://orcid.org/0000-0003-1899-814X)
- J. Wade Harper (ORCID: https://orcid.org/0000-0002-6944-7236)
- Dennis Feigenbutz (ORCID: https://orcid.org/0009-0004-8045-7787)
- Irina Dudanova (ORCID: https://orcid.org/0000-0003-1052-8485)
- Patricia Yuste‐Checa (ORCID: https://orcid.org/0000-0002-1056-3849)
- F. Ulrich Hartl (ORCID: https://orcid.org/0000-0002-7941-135X)
- Victoria A. Trinkaus (ORCID: https://orcid.org/0000-0001-8964-6120)
- Ulrich Dransfeld (ORCID: https://orcid.org/0000-0002-4054-5852)
- Maximilian Garhammer (ORCID: https://orcid.org/0000-0002-9755-4733)
- Larysa Ivashko
Institutions
- Harvard University (US)
- Max Planck Institute for Metabolism Research (DE)
- Munich Cluster for Systems Neurology (DE)
- Max Planck Institute of Biochemistry (DE)
Publication Details
- Journal
- Molecular Cell
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.molcel.2025.08.022
- Citations
- 3
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.17
Funders
- Michael J. Fox Foundation for Parkinson's Research
- Max-Planck-Förderstiftung
- Deutsche Forschungsgemeinschaft
- Max-Planck-Institut für Bildungsforschung